Graves' disease: developments in first-line antithyroid drugs in the young. (2020)

First Author: Lane LC
Attributed to:  Molecular determinants of immune tolerance in Graves' disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/17446651.2020.1735359

PubMed Identifier: 32133893

Publication URI: http://europepmc.org/abstract/MED/32133893

Type: Journal Article/Review

Volume: 15

Parent Publication: Expert review of endocrinology & metabolism

Issue: 2

ISSN: 1744-6651